These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25327891)

  • 1. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1.
    Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE
    Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1.
    Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain inflammation is accompanied by peripheral inflammation in Cstb
    Okuneva O; Li Z; Körber I; Tegelberg S; Joensuu T; Tian L; Lehesjoki AE
    J Neuroinflammation; 2016 Nov; 13(1):298. PubMed ID: 27894304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.
    Körber I; Katayama S; Einarsdottir E; Krjutškov K; Hakala P; Kere J; Lehesjoki AE; Joensuu T
    PLoS One; 2016; 11(6):e0158195. PubMed ID: 27355630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation.
    Joensuu T; Tegelberg S; Reinmaa E; Segerstråle M; Hakala P; Pehkonen H; Korpi ER; Tyynelä J; Taira T; Hovatta I; Kopra O; Lehesjoki AE
    PLoS One; 2014; 9(2):e89321. PubMed ID: 24586687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial phagocytosis dysfunction in the dentate gyrus is related to local neuronal activity in a genetic model of epilepsy.
    Sierra-Torre V; Plaza-Zabala A; Bonifazi P; Abiega O; Díaz-Aparicio I; Tegelberg S; Lehesjoki AE; Valero J; Sierra A
    Epilepsia; 2020 Nov; 61(11):2593-2608. PubMed ID: 32940364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice.
    Manninen O; Koskenkorva P; Lehtimäki KK; Hyppönen J; Könönen M; Laitinen T; Kalimo H; Kopra O; Kälviäinen R; Gröhn O; Lehesjoki AE; Vanninen R
    Radiology; 2013 Oct; 269(1):232-9. PubMed ID: 23788720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
    Vaarmann A; Kaasik A; Zharkovsky A
    Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy.
    Manninen O; Puolakkainen T; Lehto J; Harittu E; Kallonen A; Peura M; Laitala-Leinonen T; Kopra O; Kiviranta R; Lehesjoki AE
    Bone Rep; 2015 Dec; 3():76-82. PubMed ID: 28377970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive volume loss and white matter degeneration in cstb-deficient mice: a diffusion tensor and longitudinal volumetry MRI study.
    Manninen O; Laitinen T; Lehtimäki KK; Tegelberg S; Lehesjoki AE; Gröhn O; Kopra O
    PLoS One; 2014; 9(6):e90709. PubMed ID: 24603771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations.
    Alakurtti K; Weber E; Rinne R; Theil G; de Haan GJ; Lindhout D; Salmikangas P; Saukko P; Lahtinen U; Lehesjoki AE
    Eur J Hum Genet; 2005 Feb; 13(2):208-15. PubMed ID: 15483648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
    Singh S; Hämäläinen RH
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin B is essential for proliferation and interneuron migration in individuals with EPM1 epilepsy.
    Di Matteo F; Pipicelli F; Kyrousi C; Tovecci I; Penna E; Crispino M; Chambery A; Russo R; Ayo-Martin AC; Giordano M; Hoffmann A; Ciusani E; Canafoglia L; Götz M; Di Giaimo R; Cappello S
    EMBO Mol Med; 2020 Jun; 12(6):e11419. PubMed ID: 32378798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Changes in the Mitochondrial Proteome of Cerebellar Synaptosomes From Preclinical Cystatin B-Deficient Mice.
    Gorski K; Spoljaric A; Nyman TA; Kaila K; Battersby BJ; Lehesjoki AE
    Front Mol Neurosci; 2020; 13():570640. PubMed ID: 33281550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.